Status:
COMPLETED
Analysis of I-Trace High Order Aberrations Induced by Wavefront Optimized Ablation Profiles
Lead Sponsor:
Alexandria University
Conditions:
Myopia
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
This work aims at the analysis of ocular aberrations induced by wave front optimized ablation profiles WFO using I-Trace aberrometer (Ray -Tracing)
Detailed Description
The iTrace (Tracey Technologies, Houston, Tx) is uniquely designed to combine Placido corneal topography with a ray tracing aberrometer to measure quality of vision in a patient. This work aims at the...
Eligibility Criteria
Inclusion
- Myopia up to -8.0 D and astigmatism up to -2.0D.
- Cases above 18 years of age with a stable refraction for at least one year.
Exclusion
- Keratoconus.
- Patients with collagen diseases.
- Previous LASIK or any other refractive surgery.
- Severe dry eye syndrome.
Key Trial Info
Start Date :
January 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04452448
Start Date
January 10 2018
End Date
June 10 2020
Last Update
June 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Medicine
Alexandria, Egypt